Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-beta (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.

2015

Aalbers, C. J., L. Bevaart, et al. (2015).

PLoS One 10(6): e0130612.

Lire l'article